Summary & Overview
CPT 94777: Home Apnea Monitoring, 30-Day
CPT code 94777 designates a 30-day home apnea monitoring service for neonates at risk of recurrent apnea, bradycardia, and hypoxemia following hospital discharge. The code captures device-based physiologic monitoring plus clinician review, interpretation, and a formal report. Nationally, this code matters because it documents an extended remote monitoring episode that can support continuity of care during a vulnerable post-discharge period and informs payment for ambulatory monitoring services.
Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what 94777 represents clinically and operationally, common payer coverage considerations, and what to expect in claims processing for a month-long home monitoring episode. The publication summarizes typical service delivery settings, coding intent, and potential implications for post-discharge neonatal care coordination. Data not available in the input is noted where applicable. The focus is national in scope and intended for billing managers, clinical program leads, and policy analysts seeking a clear briefing on this monitoring code.
Billing Code Overview
CPT code 94777 reports home apnea monitoring for a 30-day period. This service supports continuous or intermittent monitoring of neonates at risk for recurrent apnea, bradycardia, and hypoxemia after hospital discharge. The procedure includes device-based monitoring, review and interpretation of collected physiologic data, and preparation of a formal report.
-
Service type: Home neonatal apnea monitoring with data review and reporting
-
Typical site of service: Patient's home
Clinical & Coding Specifications
Clinical Context
A term or near-term neonate discharged from the neonatal intensive care unit with recurrent episodes of apnea and intermittent bradycardia is prescribed home cardiorespiratory/apnea monitoring for up to 30 days. Typical clinical workflow: the neonate’s pediatrician or neonatologist documents the indication (e.g., recurrent apnea of prematurity, post-discharge apnea, or resolved but monitored respiratory instability) and orders home monitoring. A durable medical equipment (DME) company or hospital-based respiratory therapy team provisions a bedside or wearable apnea monitor and trains caregivers on placement, alarm response, battery management, and documentation of events. The monitor records events (apnea, bradycardia, desaturation) during the 30-day monitoring interval. A qualified clinician (often a neonatologist, pediatric pulmonologist, or pediatrician) retrieves the device data or remote transmission, reviews and interprets the recorded events, generates a formal report summarizing frequency, duration, and severity of events, and documents clinical recommendations in the medical record. Billing uses 94777 to report the professional review, interpretation, and report preparation for home apnea monitoring over the 30-day period. The typical site of service is the patient’s home for the monitoring and the clinician’s office or hospital for interpretation and reporting. Caregivers may contact the clinician for escalations; lifesaving interventions follow emergency services protocols when alarms indicate severe events.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |